Epstein Secrets

to David Sanger. Clapper said his office's "first key judgment in 2016" was that "the initial objective was to sow doubt, discord, and discontent." Clapper added that Russian actors "exploit and amplify the polarization and divisiveness" in the US. Opinion: Iran's Election Interference Aims Also To Dis

s are creating a "perception hack," meaning they want the "perception that they're inside the system, and sow distrust," according to David Sanger. Clapper said his office's "first key judgment in 2016" was that "the initial objective was to sow doubt, discord, and discontent." Clapper added that Russia

Chief Medical Officer Merdad Parsey said the drug has approvals or authorizations in around 50 countries. EFTA00148471 The New York Times (10/22, Levenson, 18.61M) reports the FDA's announcement "indicated that the drug had cleared more rigorous regulatory hurdles involving a more thorough review of c

rs are creating a "perception hack," meaning they want the "perception that they're inside the system, and sow distrust," according to David Sanger. Clapper said his office's "first key judgment in 2016" was that "the initial objective was to sow doubt, discord, and discontent." Clapper added that Russi

Chief Medical Officer Merdad Parsey EFTA00135821 said the drug has approvals or authorizations in around 50 countries. The New Ynrk TIMP4 (10/22, Levenson, 18.61M) reports the FDA's announcement "indicated that the drug had cleared more rigorous regulatory hurdles involving a more thorough review of c

rs are creating a "perception hack," meaning they want the "perception that they're inside the system, and sow distrust," according to David Sanger. Clapper said his office's "first key judgment in 2016" was that "the initial objective was to sow doubt, discord, and discontent." Clapper added that Russia

approvals or authorizations in around 50 countries. The New York Times <https://www.nytimes.com/2020/10/22/us/remdesivir-fda-approved.html> (10/22, Levenson, 18.61M) reports the FDA's announcement "indicated that the drug had cleared more rigorous regulatory hurdles involving a more thorough review of cl